These include the inhibitor of the Arp2/3 complex, Arpin50, the breast cancer anti-estrogen resistance protein 3 (BCAR3)51,52, the PDZ and LIM domain protein 1 (PDLIM1/ELFIN)53,54, the SHC-transforming protein 1 (SHC1)55, the LIM and Calponin homology domain containing protein 1 (LIMCH1)56, the E3 ubiquitin ligase Mind Bomb 1 (MIB1)57, the microtubule-associated protein 4 (MAP4)58 and the anthrax toxin and collagen I receptor, ANTXR1/TEM859,60. This evidence concerns the gene SHC1 and cancer.